Escitalopram Oxalate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

67 API Suppliers, 30 USDMF, 21 CEP/COS, 11 JDMF, 23 EU WC, 28 KDMF, 19 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

19 Intermediates Suppliers

19 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

513 FDF Dossiers, 80 FDA Orange Book, 221 Europe, 52 Canada, 44 Australia, 39 South Africa, 77 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE, SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 4 DKSH, 1 Pharm-RX Chemical, 6 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 21 BASF, 2 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

82 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 38 Direct Compression, 30 Controlled & Modified Release, 29 Thickeners and Stabilizers, 27 Solubilizers, 24 Film Formers & Plasticizers, 22 Granulation, 22 Parenteral, 21 Disintegrants & Superdisintegrants, 19 Co-Processed Excipients, 18 Taste Masking, 17 Topical, 16 Chewable & Orodispersible Aids, 14 Lubricants & Glidants, 9 Rheology Modifiers, 8 API Stability Enhancers, 8 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 7 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 128 Finished Drug Prices, 13 Annual Reports

MARKET PLACE

10 APIs, 2 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

4 US Exclusivities

4 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 3 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21365 / DOSAGE - SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ESCITALOPRAM OXALATE(UNII: 5U85DBW7LO) (ESCITALOPRAM - UNII:4O4S742ANY)	ESCITALOPRAM	5mg in 5

Inactive Ingredients

Ingredient Name	Actavis Pharma, Inc.
CITRIC ACID MONOHYDRATE(2968PHW8QP)
GLYCERIN(PDC6A3C0OX)
MALIC ACID(817L1N4CKP)
METHYLPARABEN(A2I8C7HI9T)
PEPPERMINT(V95R5KMY2B)
PROPYLENE GLYCOL(6DC9Q167V3)
PROPYLPARABEN(Z8IX2SC1OH)
SODIUM CITRATE(1Q73Q2JULR)
SORBITOL(506T60A25R)
WATER(059QF0KO0R)

Drug Product Composition: Escitalopram Oxalate